TDOC

Teladoc (TDOC) closed at $5.73, up 1.06% but down 10% over the past month. The telehealth provider is expected to report earnings on October 28, 2026, with projected EPS of -$0.23 (down 9.52% YoY) and revenue of $585.55 million (down 6.53% YoY). The company holds a Zacks Rank #3 (Hold) rating, with the Medical Services industry ranking in the bottom 37% of all industries.

Teladoc (TDOC) closed at $6.00, up 1.35% in the latest session, outperforming the S&P 500. However, the stock has declined 8.92% over the past month.

The company is expected to report negative EPS of -$0.23 and revenue of $585.55 million, down 6.53% year-over-year. Teladoc holds a Zacks Rank of #3 (Hold), with consensus EPS estimates unchanged over the last 30 days.

Teladoc Health is expanding its Solo connected care platform with two new AI-powered tools: SoloVitals, which uses smartphone cameras to estimate vital signs during virtual assessments, and SoloScribe, which automates clinical note generation and EHR integration. These additions aim to streamline remote care workflows for hospitals and strengthen Teladoc's position in the competitive virtual healthcare market.

Teladoc (TDOC) declined 3.64% in the latest trading session, significantly underperforming the broader market. The stock has depreciated 7.83% over the past month, underperforming the Medical sector.

Upcoming earnings are projected to show a loss of $0.23 per share with revenue declining 6.53% year-over-year. The company holds a Zacks Rank of #3 (Hold) with unchanged consensus EPS estimates over the last 30 days.

Teladoc stock declined 2.38% to $5.75, underperforming the broader market. The telehealth provider has dropped 7.1% over the past month, significantly worse than the Medical sector's 0.67% loss.

Upcoming earnings are projected at -$0.23 per share with quarterly revenue expected at $585.55 million, down 6.53% year-over-year. The stock holds a Zacks Rank of #3 (Hold) with recent analyst estimate revisions showing a 1.62% decrease.

The global digital health and remote patient monitoring market is projected to grow from $26.8 billion in 2025 to $80.8 billion by 2031, expanding at a 20.2% CAGR. Growth is driven by rising chronic disease management demand, expanding reimbursement coverage, and maturing wearable sensor technology, enabling a shift from episodic facility-centered care to continuous connected care models.

Holafly has launched its Ultra Plan, a new international eSIM subscription priced at €84.90/month that combines unlimited mobile data across 160+ destinations with integrated health and wellness services including 24/7 medical messaging, unlimited mental health sessions, nutritional guidance, personal training, and travel assistance. The offering targets frequent travelers, digital nomads, and students, addressing research findings that 47.5% of frequent travelers delay or forgo necessary medical care abroad.

The healthcare industry is being overlooked by investors who are primarily focused on artificial intelligence. Healthcare stocks offer relatively stable consumer spending compared to most other industries, presenting potential buying opportunities.